Skip to main content

Table 2 Analyses of overall PSA relapse*.

From: Ebp1 expression in benign and malignant prostate

  Univariate analyses
  Normal adjacent expression Tumor expression
  Hazard ratio (95% CI); Hazard ratio (95% CI);
  p-value p-value
  Cut-off (median) Cut-off (median)
Ebpl 1.75(0.79–3.89); 1.15(0.58–2.26);
  p = 0.170 p = 0.689
  Median = 2.00 Median = 2.50
Androgen Receptor 0.48 ((0.24–0.95); 0.51 (0.25–1.02);
  p = 0.035 p = 0.056
  Median = 61.25 Median = 81.67
Cyclin D1 0.34(0.17–0.69); 0.57(0.29–1.14);
  p = 0.002 p = 0.113
  Median = 2.50 Median = 14,38
ErbB3 0.42 (0.21–0.85); 1.16(0.59–2.29);
  p = 0.016 p = 0.665
  Median = 3.75 Median = 5.63
Ki67 1.03 (0.52–2.04); 1.01 (0,52–1,96);
  p = 0.936 p = 0.976
  Median = 29.50 Median = 127.25
  1. Correlation between PSA relapse and the expression of the five molecular marker expression in normal adjacent and tumor tissues using univariate Cox regression analyses. The median value used as the statistical cut-off is also shown.
  2. * Data was categorized according to the median.
  3. Univariate COX regression with the "ENTER" model
  4. Median expression was used as cut-offs for catergorized data.
  5. Bold indicates statistically significant values